Drug – bio-affecting and body treating compositions – Lymphokine
Reexamination Certificate
2005-04-26
2005-04-26
Kunz, Gary (Department: 1647)
Drug, bio-affecting and body treating compositions
Lymphokine
C424S184100, C424S198100, C514S012200, C530S351000
Reexamination Certificate
active
06884410
ABSTRACT:
Interleukin-10 for producing a population of cells which are capable of inhibiting or suppressing reactions to alloantigens, for example in graft-versus-host disease or tissue rejection, is described. Interleukin-10 for reducing responses in mixed lymphocyte response (MLR) is also described. Exogenous or induced endogenous IL-10 may be used for the inhibition or suppression of the reactions to alloantigens.
REFERENCES:
patent: 4483920 (1984-11-01), Gillespie et al.
patent: 4559310 (1985-12-01), Cantor et al.
patent: 405 980 (1991-01-01), None
Rott et al. Interleukin-10 prevents experimental allergic encephalomyelitis in rats. European Journal of immunology. vol. 24, pp. 1434-1440, 1994.*
Daniel M. Altman, et al.,Nature338:512-514, Apr. 1989. “Cotransfection of ICAM-1 and HLA-DR Reconstitutes Human Antigen-Presenting Cell Function in Mouse L Cells”.
Michael Arock, et al.,Eur. J. Immunol.26:166-170, 1996. “Interleukin-10 Inhibits Cytokine Generation from Mast Cells”.
Rosa Bacchetta, et al.,J. Immunol.144:902-908, Feb. 1990. “Host-Reactive CD4+ and CD8+ T Cell Clones Isolated from a Human Chimera Produce IL-5, IL-2, IFN-γ, and Granulocyte Macrophage Colony Stimulating Factor but Not IL-5”.
Rosa Bacchetta, et al.,J. Exp. Med.179:493-502, Feb. 1994. “High Levels of Interleukin 10 Production In Vivo Are Associated wih Tolerance in SCID Patients Transplanted with HLA Mismatched Hematopoietic Stem Cells”.
Rosa Bacchetta, et al.,J. Clin. Invest.91:1067-1078, Mar. 1993. “Chimerism and Tolerance to Host and Donor in Severe Combined Immunnodeficiencies Transplanted with Fetal Liver Sterm Cells”.
J.C. Becker, et al.International Immunology,6(10):1605-12, 1994. “Maintenance of clonal anergy by endogenously produced IL-10”.
Maria-Teresa Bejarano, et al.,Int. J. Cancer35:327-333, 1985. “Effect of Cyclosporin-A (CsA) on the Ability of T Lymphocytes Subsets to Inhibit the Proliferation of Autologous EBV-Transformed B Cells”.
Maria-Teresa Bejarano, et al.,Intl. Immunol.4:1389-1397, Sep. 1992. “Interleukin 10 Inhibits Allogeneic Proliferative and Cytotoxic T Cell Responses Generated in Primary Mixed Lymphocyte Cultures”.
Michael Bevan,Immunol. Today5:128-130, 1984. “High Determinant Density May Explain the Phenomenon of Alloreactivity”.
Avilnash Bhandoola, et al.,J. Immunol.151:2355-2367, Sep. 1, 1993. “Reduced CD3-Mediated Protein Tyrosine Phosphorylation in Anergic CD4+ and CD8+ T Cells”.
Vassiliki A. Boussiotis, et al.,J. Exp. Med.180:1665-1673, Nov. 1994. “CD2 Is Involved in Maintenance and Reversal of Human Alloantigen-specific Clonal Anergy”.
F. Cardillo, et al.European Journal of Immunology,23:2597-2605, 1993. “An age-related γδ T cell supressor activity correlates with the outcome of autoimmunity in experimental Trypanosoma cruzi infection”.
Andrew C. Chan, et al.,Ann. Rev. Immunol.12:555-592, 1994. “The Role of Protein Tyrosine Kinases and Protein Tyrosine Phosphatases in T Cell Antigen Receptor Singal Transduction”.
Chung-Hsing Chang, et al.,Eur. J. Immunol.25:394-398, 1995. “B7-1 Expression of Langerhans Cells Is Up-Regulated by Proinfalmmatory Cytokines, and Is Down-Regulated by Interferon-γ or by Inteleukin-10”.
Youchai Chen, et al.,Nature, 376:177-180, Jul. 13, 1995. “Peripheral Deletion of Antigen-Reactive T Cells in Oral Tolerance”.
Youchai Chen, et al.,Science265:1237-1240, Aug. 26, 1995. “Regulatory T Cell Clones Induced by Oral Toerance: Suppression of Autoimmune Encephalomyelitis”.
F.Q. Cunha, et al.,Biochem. Biophys. Res. Comm.182:1155-1159, Feb. 1992. “Interleukin-10 (IL-10) Inhibits the Induction of Nitric Oxide Synthetase by Interferon-γ in Murine Macrophages”.
Ammalisa D'Andrea, et al.,J. Exp. Med.178:1041-1048, Sep. 1993. “Interleukin 10 (IL-10) Inhibits Human Lymphocyte Interferon-g Production by Suppressing Natural Killer Cell Stimulatory Factor/IL-12 Sythesis in Accessory Cells”.
Dimuthu R. DeSilva, et al.,J. Immunol.147:3261-3267, Nov. 15, 1991. “Clonal Anergy Is Induced In Vitro by T Cell Receptor Occupancy in the Absence of Proliferation”.
Jan E. de Vries, et al., eds.,Interleukin-10, R.G. Landes Co., Austin, TX, title page, verso, and table of contents, 1995.
Rene de Waal Malefyt, et al.,J. Immunol.150:4754-4765, Jun. 1, 1993. “Direct Effects of IL-10 on Subsets of Human CD4+ T Cell Clones and Resting T Cells”.
René de Waal Malefyt, et al.,J. Exp. Med.174:915-924, Oct. 1991. “Interleukin 10 (IL-10) and Viral IL-10 Strongly Reduce Antigen-specific Human T Cell Proliferation by Diminishing the Antigen-presenting Capacity of Monocytes via Downregulation of Class II Major Histocompatibility Complex Expression”.
Rene de Waal Malefyt, et al.,J. Exp. Med.174:1209-1220, Nov. 1991. “Interleukin 10 (IL-10) Inhibits Cytokine Synthesis by Human Monocytes: An Autoregulatory Role of IL-10 Produced by Monocytes”.
Linna Ding, et al.,J. Immunol.151:1224=1234, Aug. 1, 1993. “IL-10 Inhibits Macrophage Costimulatory Activity by Selectively Inhibiting the Up-Regulation of B7 Expression”.
Linna Ding, et al.,J. Immunol.148:33133-3139, May 15, 1992. “IL-10 Inhibits Mitogen-Induced T Cell Proliferation by Selectively Inhibitn Macrophage Costimulatory Function”.
A. Enk, et al.Journal of Experimental Medicine, 179:1397-1402, 1994. “Induction of Hapten-specific Tolerance by Interleukin 10 In Vivo”.
Stephan Fasler, et al.,J. Immunol.155:4199-4206, 1995. “Peptide-Induced Anergy in Allergen-Specific Human Th2 Cells Results in Lack of Cytokine Production and B Cell Help for IgE Synthesis”.
Patrick E. Fields, et al.,Science271:1276-1278, 1996 “Blocked Ras Activation in Anergic CD4+ T Cells”.
David F. Florentino, et al.,J. Exp. Med.170:2081-2095, Dec. 1989. “Two Types of Mouse T Helper Cell: IV. Th2 Clones Secrete a Factor that Inhibits Cytokine Production by Th1 Clones”.
David F. Fiorentino, et al,J. Immunol.146:3444-3451, May 1991, “IL-10 Acts on the Antigen-Presenting Cell to Inhibit Cytokine Production by Th1 Cells”.
Stephen J. Forman, et al.,Bone Marrow Transplantation, Blackwell Scientific Publications, Cambridge, MA, Chapter 4, verso and pp. 37-38, 1994.
James D. Fraser, et al.,Immunol. Today14:357-362, 1993. “Signal Transduction Events Leading to T-Cell Lymphokine Gene Expression”.
Arnold S. Freedman, et al.,J. Immunol.139:3260-3267, Nov. 1987. “B7, a B Cell-Restricted Antigen that Identifies Preactivated B Cells”.
Ricardo T. Gazzinelli, et al.,J. Immunol.148:1792-1796, 1992. “IL-10 Inhibits Parasite Killing and Nitrogen Oxide Production by IFN-g-Activated Macrophages”.
Ning Fei Go, et al.,J. Exp. Med.172:1625-1631, Dec. 1990. “Interleukin 10, a Novel B Cell Stimulatory Factor: Unresponsiveness of X Chromosome-Linked Immunodeficiency B Cells”.
Hervé Groux, et al.,J. Exp. Med.184:19-29, Jul. 1996. “Interleukin-10 Induces a Long-Term Antigen-Specific Anergic State in Human CD4+ T Cells”.
Clifford V. Harding, et al.,Proc. Natl. Acad Sci.87:5553-5557, Jul. 1990. “Functional and Ultrastructrual Evidence for Intracellular Formation of Major Histocmpatibility Complex Class II-Peptide Complexes during Antigen Processing”.
Chyi-Song Hseih, et al.,Science260:547-549, Apr. 1993. “Development of Th1 CD4+ T Cells through IL-12 Produced by Listeria-Induced Macrophages”.
Di-Hwei Hsu, et al.,Science, 250:830-832, Nov. 1990. “Expression of Interleukin-10 Activity by Epstein-Barr Virus Protein BCRFI”.
Marc K. Jenkins,Immunol. Today13:69-73, 1992. “The Role of Cell Division in the Induction of Clonal Anergy”.
Marc Jenkins, et al.,J. Immunol.144:16-22, Jan. 1, 1990. “Inhibition of Antigen-Specific Proliferation of Type 1 Murine T Cell Clone
Bacchetta Rosa
de Vries Jan E.
de Waal Malefyt Rene
Groux Herve M.
Roncarolo Maria-Grazia
Ching Edwin P.
Hamud Fozia
Hill Laurie L.
Kunz Gary
Schering Corporation
LandOfFree
Methods for modulating antigen-specific immune responses does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for modulating antigen-specific immune responses, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for modulating antigen-specific immune responses will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3394776